XML 39 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Document and Entity Information - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Mar. 24, 2022
Jun. 30, 2021
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Transition Report false    
Amendment Flag false    
Entity Central Index Key 0001733257    
Document Fiscal Period Focus FY    
Current Fiscal Year End Date --12-31    
Document Fiscal Year Focus 2021    
Document Period End Date Dec. 31, 2021    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
ICFR Auditor Attestation Flag false    
Entity File Number 001-40227    
Entity Registrant Name FINCH THERAPEUTICS GROUP, INC.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 82-3433558    
Entity Address, Address Line One 200 Inner Belt Road    
Entity Address, Address Line Two Suite 400    
Entity Address, City or Town Somerville    
Entity Address, State or Province MA    
Entity Address, Postal Zip Code 02143    
City Area Code 617)    
Local Phone Number 229-6499    
Title of 12(b) Security Common Stock, $0.001 par value per share    
Trading Symbol FNCH    
Security Exchange Name NASDAQ    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company true    
Entity Ex Transition Period false    
Entity Shell Company false    
Entity Common Stock, Shares Outstanding   47,532,573  
Entity Public Float     $ 354.9
Documents Incorporated by Reference

Portions of the registrant’s proxy statement for the 2022 annual meeting of stockholders to be filed pursuant to Regulation 14A within 120 days after the registrant’s fiscal year ended December 31, 2021, are incorporated by reference in Part III of this Form 10-K.

    
Auditor Name Deloitte & Touche LLP    
Auditor Location Boston, Massachusetts    
Auditor Firm ID 34